Maxrel Pharmaceuticals Private Limited
About Maxrel Pharmaceuticals Private Limited
Data last updated:
Maxrel Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 13 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2016PTC299619. Its GSTIN is 06AAKCM3227A1ZX (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dilbag Singh and Sandip Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 155 Khasra No. 72/22/23 Mundka, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.76 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.2 Lakh (net margin 0.7%) and EBITDA of ₹4.17 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address# 155 Khasra No. 72/22/23 Mundka, Delhi, India – 110041
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxrel Pharmaceuticals Private Limited
The main business activity of Maxrel Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Maxrel Pharmaceuticals Private Limited
Maxrel Pharmaceuticals Private Limited is audited by MEHTANI ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MEHTANI ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maxrel Pharmaceuticals Private Limited
Maxrel Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilbag Singh | Director | 05 Jul 2016 | 10 Years 3 Months | Current |
| Sandip Garg | Director | 13 May 2016 | 10 Years 4 Months | Current |
Financials of Maxrel Pharmaceuticals Private Limited FY 2025 filings available
Maxrel Pharmaceuticals Private Limited reported revenue of ₹1.76 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxrel Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 22% growth in the latest year. EBITDA rose 211% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxrel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.17 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.2 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxrel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxrel Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maxrel Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxrel Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Sep 2022 | State Bank of India | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Maxrel Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Maxrel Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Maxrel Pharmaceuticals Private Limited
Maxrel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCM3227A1ZX | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Maxrel Pharmaceuticals Private Limited
Maxrel Pharmaceuticals Private Limited has 4 court cases on record: 4 filed by Maxrel Pharmaceuticals. 2 cases are pending and 2 are disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
Latest cases (3 of 4; higher courts first)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hisar, Haryana | Civil suit | Filed by the company against Peer Enterprises | Pending |
| District court, Hisar, Haryana | Civil suit | Filed by the company against Sajad Traders | Pending |
| District court, Hisar, Haryana | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Maxrel Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxrel Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxrel Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxrel Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Maxrel Pharmaceuticals Private Limited
Frequently Asked Questions about Maxrel Pharmaceuticals Private Limited
Maxrel Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 13 May 2016 (10+ years old) and is registered under CIN U51909DL2016PTC299619.
Maxrel Pharmaceuticals reported revenue of ₹1.76 Cr for FY 2025 (up 22% YoY).
Maxrel Pharmaceuticals has 2 current directors:
- Dilbag Singh - Director
- Sandip Garg - Director
Maxrel Pharmaceuticals reported a net profit of ₹1.2 Lakh (net margin 0.7%) and EBITDA of ₹4.17 Lakh (EBITDA margin 2.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxrel Pharmaceuticals is 19% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxrel Pharmaceuticals is 06AAKCM3227A1ZX, registered in Haryana.
The CIN (Corporate Identification Number) of Maxrel Pharmaceuticals is U51909DL2016PTC299619. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxrel Pharmaceuticals has 4 court cases on record: 4 filed by the company. 2 are pending.
Maxrel Pharmaceuticals was incorporated on 13 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.